These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27917593)

  • 1. Α Markov model for longitudinal studies with incomplete dichotomous outcomes.
    Efthimiou O; Welton N; Samara M; Leucht S; Salanti G;
    Pharm Stat; 2017 Mar; 16(2):122-132. PubMed ID: 27917593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled pattern imputation for sensitivity analysis of longitudinal binary and ordinal outcomes with nonignorable dropout.
    Tang Y
    Stat Med; 2018 Apr; 37(9):1467-1481. PubMed ID: 29333672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of pattern-mixture models in randomized clinical trials.
    Bunouf P; Molenberghs G
    Pharm Stat; 2016 Nov; 15(6):494-506. PubMed ID: 27658505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A shared-parameter continuous-time hidden Markov and survival model for longitudinal data with informative dropout.
    Bartolucci F; Farcomeni A
    Stat Med; 2019 Mar; 38(6):1056-1073. PubMed ID: 30324662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian modeling and inference for clinical trials with partial retrieved data following dropout.
    Chen Q; Chen MH; Ohlssen D; Ibrahim JG
    Stat Med; 2013 Oct; 32(24):4180-95. PubMed ID: 23620446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment effects in randomized longitudinal trials with different types of nonignorable dropout.
    Yang M; Maxwell SE
    Psychol Methods; 2014 Jun; 19(2):188-210. PubMed ID: 24079928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study.
    Kolamunnage-Dona R; Powell C; Williamson PR
    Trials; 2016 Apr; 17(1):222. PubMed ID: 27125779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the handling of missing longitudinal outcome data in clinical trials.
    Powney M; Williamson P; Kirkham J; Kolamunnage-Dona R
    Trials; 2014 Jun; 15():237. PubMed ID: 24947664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finite Mixtures of Hidden Markov Models for Longitudinal Responses Subject to Drop out.
    Marino MF; Alfò M
    Multivariate Behav Res; 2020; 55(5):647-663. PubMed ID: 31559866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling and simulation of the Positive and Negative Syndrome Scale (PANSS) time course and dropout hazard in placebo arms of schizophrenia clinical trials.
    Pilla Reddy V; Kozielska M; Johnson M; Suleiman AA; Vermeulen A; Liu J; de Greef R; Groothuis GM; Danhof M; Proost JH
    Clin Pharmacokinet; 2012 Apr; 51(4):261-75. PubMed ID: 22420580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transition model for ordinal response data with random dropout: an application to the fluvoxamine data.
    Ghahroodi ZR; Ganjali M; Berridge D
    J Biopharm Stat; 2009 Jul; 19(4):658-71. PubMed ID: 20183432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian sensitivity model for intention-to-treat analysis on binary outcomes with dropouts.
    Kaciroti NA; Schork MA; Raghunathan T; Julius S
    Stat Med; 2009 Feb; 28(4):572-85. PubMed ID: 19072769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new Bayesian joint model for longitudinal count data with many zeros, intermittent missingness, and dropout with applications to HIV prevention trials.
    Wu J; Chen MH; Schifano ED; Ibrahim JG; Fisher JD
    Stat Med; 2019 Dec; 38(30):5565-5586. PubMed ID: 31691322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parametric models for incomplete continuous and categorical longitudinal data.
    Kenward MG; Molenberghs G
    Stat Methods Med Res; 1999 Mar; 8(1):51-83. PubMed ID: 10347860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A random-effects Markov transition model for Poisson-distributed repeated measures with non-ignorable missing values.
    Li J; Yang X; Wu Y; Shoptaw S
    Stat Med; 2007 May; 26(12):2519-32. PubMed ID: 17106918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype-based pharmacogenetic analysis for longitudinal quantitative traits in the presence of dropout.
    Tzeng JY; Lu W; Farmen MW; Liu Y; Sullivan PF
    J Biopharm Stat; 2010 Mar; 20(2):334-50. PubMed ID: 20309762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A latent variable approach in simultaneous modeling of longitudinal and dropout data in schizophrenia trials.
    Goyal N; Gomeni R
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1570-6. PubMed ID: 23602612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian informative dropout model for longitudinal binary data with random effects using conditional and joint modeling approaches.
    Chan JS
    Biom J; 2016 May; 58(3):549-69. PubMed ID: 26467236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling missingness for time-to-event data: a case study in osteoporosis.
    Neuenschwander B; Branson M
    J Biopharm Stat; 2004 Nov; 14(4):1005-19. PubMed ID: 15587977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.